Sleep disturbances in Parkinsonism

Area of Science:

• Neurology
• Sleep Medicine
• Movement Disorders

Background:

• Sleep disturbances significantly impact the quality of life for Parkinson's Disease (PD) patients, alongside depression and dependence.
• A comprehensive review of existing literature informed the classification of sleep-arousal disturbances specific to PD.
• Current therapeutic guidelines for PD-related sleep issues require a structured, evidence-based approach.

Purpose of the Study:

• To propose a novel, three-step model for the diagnosis and management of sleep disturbances in Parkinson's Disease patients.
• To provide a framework for improving nighttime sleep for PD patients, their spouses, and caregivers.
• To explore how optimized sleep management may postpone retirement and institutionalization in PD patients.

Main Methods:

• Detailed anamnesis from patients and caregivers to accurately diagnose sleep disorders and comorbidities.
• Utilizing a symptom diary for one week to capture sleep patterns.
• Employing various diagnostic tools including polysomnography (PSG), Epworth Sleepiness Scale, and actigraphy.
• Classifying specific sleep-arousal disturbances such as Light Fragmented Sleep (LFS), Abnormal Motor Activity During Sleep (AMADS), REM Behavior Disorders (RBD), Sleep Related Breathing Disorders (SRBD), Sleep Related Hallucinations (SRH), Sleep Related Psychotic Behavior (SRPB), Sleep Attacks (SA), and Excessive Daytime Sleepiness (EDS).
• Implementing a three-step therapeutic approach: diagnosis, non-specific therapy (including dopaminergic adjustment), and specific therapies tailored to each disorder.

Main Results:

• A classification system for PD-related sleep-arousal disturbances is presented.
• A three-step therapeutic model is outlined, encompassing diagnosis, non-specific management, and targeted treatments.
• Specific pharmacological and non-pharmacological interventions are suggested for each identified sleep disorder.
• Dopaminergic adjustments are highlighted as crucial due to the disease's progression and altered neurotransmitter activity affecting sleep.
• REM sleep deprivation, achieved through cholinergic receptor activity suppression (e.g., via L-Dopa), can ameliorate PD motor symptoms.

Conclusions:

• The proposed three-step model offers a structured approach to managing sleep disturbances in Parkinson's Disease.
• Accurate diagnosis and individualized therapy are essential for optimizing sleep and quality of life in PD patients.
• Effective management of sleep disturbances may contribute to delaying functional decline, retirement, and institutionalization.